IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 49.92 USD -2.8% Market Closed
Market Cap: 635m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one IRMD stock under the Base Case scenario is 30.67 USD. Compared to the current market price of 49.92 USD, IRadimed Corp is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IRMD Relative Value
Base Case
30.67 USD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.7
P/S
P/S
Price to Sales
8.7
vs History
47
vs Industry
14
Median 3Y
8.6
Median 5Y
8.7
Industry
2.2
Forward
7.8
More Details
33
P/E
P/E
Price to Earnings
33
vs History
65
vs Industry
16
Median 3Y
33.9
Median 5Y
37.2
Industry
21.9
Forward
27.9
More Details
24.8
P/OCF
P/OCF
Price to OCF
24.8
vs History
93
vs Industry
14
Median 3Y
38.8
Median 5Y
38.9
Industry
13.5
More Details
37.7
P/FCFE
P/FCFE
Price to FCFE
37.7
vs History
77
vs Industry
12
Median 3Y
48.9
Median 5Y
46.5
Industry
19.2
More Details
7.3
P/B
P/B
Price to Book Value
7.3
vs History
34
vs Industry
9
Median 3Y
7.3
Median 5Y
6.5
Industry
2.1
More Details
7.9
EV/S
EV/S
Enterprise Value to Sales
7.9
vs History
39
vs Industry
14
Median 3Y
7.8
Median 5Y
7.7
Industry
2.3
Forward
7.2
More Details
10.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.3
vs History
41
vs Industry
18
Median 3Y
10.2
Median 5Y
9.9
Industry
4.8
More Details
25.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.6
vs History
63
vs Industry
11
Median 3Y
25.9
Median 5Y
27.5
Industry
11.7
More Details
26.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.5
vs History
57
vs Industry
16
Median 3Y
26.6
Median 5Y
28.6
Industry
15.9
Forward
22.7
More Details
22.7
EV/OCF
EV/OCF
Enterprise Value to OCF
22.7
vs History
88
vs Industry
16
Median 3Y
35.3
Median 5Y
35.3
Industry
13.3
More Details
34.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
34.6
vs History
68
vs Industry
12
Median 3Y
44.7
Median 5Y
40.9
Industry
16.8
More Details
13.2
EV/IC
EV/IC
Enterprise Value to IC
13.2
vs History
58
vs Industry
5
Median 3Y
14.2
Median 5Y
13.6
Industry
1.8
More Details

Multiples Across Competitors

IRMD Competitors Multiples
IRadimed Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
IRadimed Corp
NASDAQ:IRMD
634.5m USD 8.7 33 25.6 26.5
US
Abbott Laboratories
NYSE:ABT
215.5B USD 5.1 16.1 21.6 31.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.8B USD 19.3 69.3 53.4 64.7
US
Boston Scientific Corp
NYSE:BSX
132.2B USD 7.9 71.3 32.8 46.2
US
Stryker Corp
NYSE:SYK
131.9B USD 5.8 44.1 22.9 27.7
IE
Medtronic PLC
NYSE:MDT
106.4B USD 3.2 25 13.4 18.9
US
Becton Dickinson and Co
NYSE:BDX
60.1B USD 2.9 34.4 14.6 26.3
DE
Siemens Healthineers AG
XETRA:SHL
47.4B EUR 2.1 24.2 14.1 20.1
US
Edwards Lifesciences Corp
NYSE:EW
40.8B USD 7.5 9.8 22.9 25.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
258.6B CNY 7 20.9 18.1 18.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
32.1B USD 8.2 36.2 25.8 28.7

See Also

Summary
IRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IRMD stock valuation using valuation multiples.
Wall Street Estimates
IRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 244,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.